Journal of Medical Virology,
Journal Year:
2023,
Volume and Issue:
95(6)
Published: May 31, 2023
Abstract
Severe
acute
respiratory
syndrome
coronavirus
2
(SARS‐CoV‐2)
is
the
etiological
pathogen
of
disease
2019
(COVID‐19),
a
highly
contagious
disease,
spreading
quickly
and
threatening
global
public
health.
The
symptoms
COVID‐19
vary
from
mild
reactions
to
severe
distress
or
even
fatal
outcomes
probably
due
different
status
host
immunity
against
virus.
Here
in
study,
we
unveiled
plasma
proteomic
signatures
transcriptional
patterns
peripheral
blood
mononuclear
cells
(PBMCs)
using
samples
10
patients
with
severity.
Through
systemic
analysis,
α‐defensin‐1
(DEFA1)
was
identified
be
elevated
both
PBMCs,
correlated
severity
stages.
In
vitro
study
demonstrated
that
DEFA1
secreted
immunocytes
suppressed
SARS‐CoV‐2
infection
original
mutated
strains
dose
dependency.
By
sequencing
data,
discovered
activated
monocytes
through
NF‐κB
signaling
pathway
after
infection,
into
circulation
perturb
by
interfering
protein
kinase
C
expression.
It
worked
mainly
during
virus
replication
instead
entry
cells.
Together,
anti‐SARS‐CoV‐2
mechanism
has
corner
how
innate
explored
its
clinical
potential
prognosis
therapeutic
intervention.
The
COVID-19
global
pandemic
caused
by
the
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
infection
has
infected
hundreds
of
millions
individuals.
Following
infection,
a
subset
can
develop
wide
range
chronic
symptoms
affecting
diverse
organ
systems
referred
to
as
post-acute
sequelae
SARS-CoV-2
(PASC),
also
known
long
COVID.
A
National
Institutes
Health-sponsored
initiative,
RECOVER:
Researching
COVID
Enhance
Recovery,
sought
understand
basis
in
large
cohort.
Given
that
occur
COVID,
mechanisms
may
underlie
these
be
diverse.
In
this
review,
we
focus
on
emerging
literature
supporting
role(s)
viral
persistence
or
reactivation
viruses
play
PASC.
Persistence
RNA
antigens
is
reported
some
organs,
yet
mechanism
which
they
do
so
and
how
associated
with
pathogenic
immune
responses
unclear.
Understanding
RNA,
antigen
other
reactivated
relate
specific
inflammatory
drive
PASC
provide
rationale
for
treatment.
Immunological Reviews,
Journal Year:
2023,
Volume and Issue:
321(1), P. 246 - 262
Published: Oct. 12, 2023
Summary
Cell
death
can
be
executed
through
distinct
subroutines.
PANoptosis
is
a
unique
inflammatory
cell
modality
involving
the
interactions
between
pyroptosis,
apoptosis,
and
necroptosis,
which
mediated
by
multifaceted
PANoptosome
complexes
assembled
via
integrating
components
from
other
modalities.
There
growing
interest
in
process
function
of
PANoptosis.
Accumulating
evidence
suggests
that
occurs
under
diverse
stimuli,
for
example,
viral
or
bacterial
infection,
cytokine
storm,
cancer.
Given
impact
across
disease
spectrum,
this
review
briefly
describes
relationships
highlights
key
molecules
formation
activation,
outlines
roles
diseases
together
with
potential
therapeutic
targeting.
We
also
discuss
important
concepts
pressing
issues
future
research.
Improved
understanding
its
mechanisms
crucial
identifying
novel
targets
strategies.
Science Immunology,
Journal Year:
2024,
Volume and Issue:
9(92)
Published: Feb. 9, 2024
Human
infection
challenge
permits
in-depth,
early,
and
pre-symptomatic
characterization
of
the
immune
response,
enabling
identification
factors
that
are
important
for
viral
clearance.
Here,
we
performed
intranasal
inoculation
34
young
adult,
seronegative
volunteers
with
a
pre-Alpha
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
strain.
Of
these
participants,
18
(53%)
became
infected
showed
an
interferon-dominated
mediator
response
divergent
kinetics
between
nasal
systemic
sites.
Peripheral
CD4
Immunological Reviews,
Journal Year:
2022,
Volume and Issue:
309(1), P. 12 - 24
Published: July 1, 2022
Abstract
Severe
acute
respiratory
syndrome
coronavirus
2
(SARS‐CoV‐2),
the
causative
agent
of
disease
2019
(COVID‐19),
has
caused
millions
deaths
in
past
two
years.
Although
initially
little
was
understood
about
this
virus,
recent
research
significantly
advanced
and
landed
interferons
(IFNs)
spotlight.
While
Type
I
III
IFN
have
long
been
known
as
central
to
antiviral
immunity,
case
COVID‐19
their
role
controversial.
However,
protective
function
is
now
well
supported
by
identification
human
deficiencies
responses
a
predictor
severity.
Here,
we
will
review
cell
types
pathways
that
lead
production
importance
timing
location
for
outcome.
We
further
discuss
mechanisms
SARS‐CoV‐2
uses
evade
responses,
current
efforts
implement
IFNs
therapeutics
treatment
COVID‐19.
It
essential
understand
relationships
between
better
inform
treatments
exploit
functions
alleviate
Molecular Cell,
Journal Year:
2022,
Volume and Issue:
82(21), P. 4131 - 4144.e6
Published: Oct. 21, 2022
RIG-I
is
an
essential
innate
immune
receptor
for
detecting
and
responding
to
infection
by
RNA
viruses.
specifically
recognizes
the
unique
molecular
features
of
viral
molecules
selectively
distinguishes
them
from
closely
related
RNAs
abundant
in
host
cells.
The
physical
basis
this
exquisite
selectivity
revealed
through
a
series
high-resolution
cryo-EM
structures
complex
with
ligands.
These
studies
demonstrate
that
actively
samples
double-stranded
cytoplasm
adopting
two
different
types
protein
folds.
Upon
binding
RNA,
adopts
high-affinity
conformation
conducive
signaling,
while
induces
autoinhibited
stimulates
release.
By
coupling
folding
selectivity,
differ
as
little
one
phosphate
group,
thereby
explaining
selective
antiviral
sensing
induction
autoimmunity
upon
dysregulation.
Proceedings of the National Academy of Sciences,
Journal Year:
2023,
Volume and Issue:
120(35)
Published: Aug. 22, 2023
Several
coronavirus
(CoV)
encoded
proteins
are
being
evaluated
as
targets
for
antiviral
therapies
COVID-19.
Included
in
these
drug
is
the
conserved
macrodomain,
or
Mac1,
an
ADP-ribosylhydrolase
and
ADP-ribose
binding
protein
a
small
domain
at
N
terminus
of
nonstructural
3.
Utilizing
point
mutant
recombinant
viruses,
Mac1
was
shown
to
be
critical
both
murine
hepatitis
virus
(MHV)
severe
acute
respiratory
syndrome
(SARS)-CoV
virulence.
However,
potential
target,
it
imperative
understand
how
complete
deletion
impacts
replication
pathogenesis
different
CoVs.
To
this
end,
we
created
bacterial
artificial
chromosomes
(BACs)
containing
deletions
(ΔMac1)
MHV,
MERS-CoV,
SARS-CoV-2.
While
were
unable
recover
infectious
from
MHV
MERS-CoV
ΔMac1
BACs,
SARS-CoV-2
readily
recovered
BAC
transfection,
indicating
stark
difference
requirement
between
Furthermore,
replicated
near
wild-type
levels
multiple
cell
lines
susceptible
infection.
mouse
model
infection,
quickly
cleared
causing
minimal
pathology
without
any
morbidity.
induced
increased
interferon
(IFN)
IFN-stimulated
gene
expression
culture
mice,
that
blocks
IFN
responses
which
may
contribute
its
attenuation.
infection
also
led
reduction
inflammatory
monocytes
neutrophils.
These
results
demonstrate
only
minimally
replication,
unlike
but
required
unique
target.
The Journal of Experimental Medicine,
Journal Year:
2023,
Volume and Issue:
220(5)
Published: March 3, 2023
X-linked
recessive
deficiency
of
TLR7,
a
MyD88-
and
IRAK-4–dependent
endosomal
ssRNA
sensor,
impairs
SARS-CoV-2
recognition
type
I
IFN
production
in
plasmacytoid
dendritic
cells
(pDCs),
thereby
underlying
hypoxemic
COVID-19
pneumonia
with
high
penetrance.
We
report
22
unvaccinated
patients
autosomal
MyD88
or
IRAK-4
infected
(mean
age:
10.9
yr;
2
mo
to
24
yr),
originating
from
17
kindreds
eight
countries
on
three
continents.
16
were
hospitalized:
six
moderate,
four
severe,
critical
pneumonia,
one
whom
died.
The
risk
increased
age.
invasive
mechanical
ventilation
was
also
much
greater
than
age-matched
controls
the
general
population
(OR:
74.7,
95%
CI:
26.8–207.8,
P
<
0.001).
patients’
susceptibility
can
be
attributed
impaired
TLR7-dependent
by
pDCs,
which
do
not
sense
correctly.
Patients
inherited
long
thought
selectively
vulnerable
pyogenic
bacteria,
but
have
pneumonia.
Journal of Medical Virology,
Journal Year:
2023,
Volume and Issue:
95(3)
Published: Feb. 9, 2023
Severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
is
a
poor
inducer
of
innate
antiviral
immunity,
and
the
underlying
mechanism
still
needs
further
investigation.
Here,
we
reported
that
SARS-CoV-2
NSP7
inhibited
production
type
I
III
interferons
(IFNs)
by
targeting
RIG-I/MDA5,
Toll-like
receptor
(TLR3)-TRIF,
cGAS-STING
signaling
pathways.
suppressed
expression
IFNs
IFN-stimulated
genes
induced
poly
(I:C)
transfection
infection
with
Sendai
virus
or
virus-like
particles.
impaired
IFN
activated
components
cytosolic
dsRNA-sensing
pathway,
including
RIG-I,
MDA5,
MAVS,
but
not
TBK1,
IKKε,
IRF3-5D,
an
active
form
IRF3.
In
addition,
also
TRIF-
STING-induced
responses.
Mechanistically,
associated
RIG-I
MDA5
prevented
formation
RIG-I/MDA5-MAVS
signalosome
interacted
TRIF
STING
to
inhibit
TRIF-TBK1
STING-TBK1
complex
formation,
thus
reducing
subsequent
IRF3
phosphorylation
nuclear
translocation
are
essential
for
induction.
ectopic
impeded
immune
activation
facilitated
replication.
Taken
together,
dampens
responses
via
disruption
signal
transduction
RIG-I/MDA5-MAVS,
TLR3-TRIF,
pathways,
providing
novel
insights
into
interactions
between
immunity.
Defective
viral
genomes
(DVGs)
are
generated
ubiquitously
in
many
RNA
viruses,
including
SARS-CoV-2.
Their
interference
activity
to
full-length
viruses
and
IFN
stimulation
provide
the
potential
for
them
be
used
novel
antiviral
therapies
vaccine
development.